The TRIDENT study is for patients recently diagnosed with glioblastoma (GBM). This clinical trial is evaluating the safety and efficacy of Tumor Treating Fields (TTFields) delivered by the Optune® treatment paired with radiation therapy and temozolomide in newly diagnosed GBM patients [About TTFields].
All patients participating in this study will receive Optune® treatment [The TRIDENT Trial].
Please visit the Novocure Trident Trial
site for more details.